CD8A and neoplasm: Indeed, in a deeper analysis of these TILs, mice treated with LPF presented a significant (p < 0.01) increase in tumor specific T cells (Tetramer+/CD8+) and activated tumor specific lymphocytes (PD1+Tetramer+/CD8+), reflecting a specific antigen response at the local target.